Co-Founding CEO (Metabolic & Inflammation Therapies)
Core
Lead all aspects of a biotech venture's growth, from strategy to advancing first programs into clinical trials for diabetic kidney disease and other metabolic diseases.
Role type
Co-Founding CEO (Biotech)
Builds
First-in-class therapeutic platform targeting RAGE/DIAPH1 interaction to treat diabetic kidney disease and other metabolic conditions
Domain
Biotechnology / Metabolic Diseases / Kidney Disease
Required skills
Early-stage venture leadership, fundraising (seed/Series A), strategic indication selection, preclinical to clinical development management, team building, scientific-commercial translation
Preferred skills
Scientific understanding of metabolic diseases, relationship building with investors and scientific community, adaptability in dynamic startup environments
Technologies
RAGE biology, small molecule therapeutics, IND submission processes
Responsibilities
Define and execute company strategy aligning science, operations, and business goals; Lead fundraising and secure strategic collaborations; Choose and prioritize indication strategy; Oversee transition from preclinical to IND submission and clinical development; Build and manage the team; Represent the venture to investors, partners, and the scientific community
Seniority
Co-founder / Leadership